Sleep Aids - Japan

  • Japan
  • Revenue in the Sleep Aids market amounts to €28.06m in 2024. The market is expected to grow annually by 5.77% (CAGR 2024-2029).
  • In global comparison, most revenue is generated in the United States (€1,950m in 2024).
  • In relation to total population figures, per person revenues of €0.23 are generated in 2024.

Key regions: Thailand, Indonesia, United States, Europe, Philippines

Comparaison de régions

Analyst Opinion

The Sleep Aids market in Japan is experiencing steady growth due to changing customer preferences and increasing awareness about the importance of sleep.

Customer preferences:
Japanese consumers are becoming more health-conscious and are prioritizing their well-being. As a result, there is a growing demand for products that can help improve sleep quality. Sleep aids, such as herbal supplements, sleep trackers, and aromatherapy products, are gaining popularity among consumers who are looking for natural and non-invasive ways to enhance their sleep.

Trends in the market:
One of the key trends in the Sleep Aids market in Japan is the rising popularity of herbal sleep aids. Traditional Japanese medicine, known as Kampo, is gaining traction as a natural alternative to pharmaceutical sleep aids. Kampo remedies, which are based on a combination of herbs and other natural ingredients, are believed to promote relaxation and improve sleep quality. This trend is driven by the increasing preference for natural and holistic approaches to health and wellness. Another trend in the market is the growing adoption of sleep trackers and smart sleep devices. These devices use advanced technology to monitor sleep patterns and provide insights on sleep quality. Japanese consumers, who are known for their interest in technology and data-driven solutions, are embracing these devices as a way to track and optimize their sleep. The availability of sleep data through these devices also allows consumers to identify potential sleep issues and seek appropriate solutions.

Local special circumstances:
Japan has a unique cultural context that influences the Sleep Aids market. The Japanese society places a high value on work and productivity, often leading to long working hours and high levels of stress. This can negatively impact sleep quality and increase the demand for sleep aids. Additionally, the aging population in Japan is driving the need for sleep aids as older individuals often experience sleep disturbances and insomnia.

Underlying macroeconomic factors:
Japan has a stable economy with a high standard of living, allowing consumers to prioritize their health and well-being. The country also has a well-developed healthcare system and a strong focus on preventive healthcare. This creates a favorable environment for the Sleep Aids market to thrive as consumers are willing to invest in products that can improve their sleep and overall quality of life. In conclusion, the Sleep Aids market in Japan is witnessing growth due to changing customer preferences, including the increasing demand for natural sleep aids and the adoption of sleep tracking devices. The unique cultural context and macroeconomic factors in Japan further contribute to the development of the market. As consumers continue to prioritize their sleep and well-being, the Sleep Aids market in Japan is expected to continue its upward trajectory.


Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Vue d’ensemble

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Veuillez patienter


Des questions ? Nous nous ferons un plaisir de vous aider.
Statista Locations
Contact Temitope Ifekoya
Temitope Ifekoya
Customer Relations

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (États-Unis)

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asie)

Lun - Ven, 9:00 - 17:00 h (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asie)

Lun - Ven, 10:00 - 18:00 h (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Lun - Ven, 9:00 - 18:00 h (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Amérique latine)

Lun - Ven, 9:00 - 18:00 h (EST)